Page last updated: 2024-09-04

cinacalcet and Bone Diseases, Metabolic

cinacalcet has been researched along with Bone Diseases, Metabolic in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (25.00)29.6817
2010's23 (71.88)24.3611
2020's1 (3.13)2.80

Authors

AuthorsStudies
Al-Ahmad, RA; Alhasan, KA; Kari, JA; Sheerah, AA1
Ito, M; Koshika, M; Kudo, K; Masakane, I; Nishida, H; Nishida, W; Tanida, H; Tomita, Y1
Kitazono, T; Tsuruya, K; Yamada, S1
Moe, SM; Thadhani, R1
Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; London, GM; Mahaffey, KW; Modafferi, DM; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC1
Cozzolino, M; Goldsmith, D; Ketteler, M; Khan, S; Martin, KJ; Sharma, A1
Ayav, C; Brunaud, L; Erpelding, ML; Filipozzi, P; Frimat, L; Kessler, M1
Behets, GJ; D'Haese, PC; De Broe, ME; Goodman, WG; Spasovski, G; Spiegel, DM; Sterling, LR1
Abdelrahman, M; Abdulkader, M; Algareeb, A; Awn, NM; Karkar, A; Mushtaque, F; Nassar, M; Qadi, Y; Sabry, A; Shaheen, FA; Sinha, AK; Souqiyyeh, MZ; Taha, MI1
Acosta Martínez, Y; Borrego Utiel, FJ; Bravo Soto, JA; García Álvarez, T; González Carmelo, I; López Jiménez, V; Mazuecos Blanca, MA; Merino Pérez, MJ1
Ito, T; Iwashita, Y; Shigematsu, T1
Ballarin, J; Bover, J; DaSilva, I; Diaz-Encarnacion, MM; Fernández, E; Lloret, MJ; Mateu, S; Mercado, C; Ruiz, C; Ureña-Torres, P1
Covit, A; Pepe, J; Shastri, J; Sherman, RA; Tran, A1
Bahner, U; Brandl, M; Nies, C; Schmidt-Gayk, H1
Hamano, T2
Fukagawa, M; Suzuki, M1
Fukagawa, M; Komaba, H; Nakai, K1
Shaheen, FA; Souqiyyeh, MZ1
Andres, A; Gutierrez, E; Morales, E1
Yokoyama, K1
Taniguchi, M1
Koiwa, F; Maruta, Y1
Kakuta, T; Uemura, K1
Lewin, E; Olgaard, K; Silver, J1
Akizawa, T; Mizobuchi, M; Nakazawa, A1
Jiang, W; Li, D; Shao, L; Xu, Y; Zhang, W; Zhou, H1
Imanishi, Y1
Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Hasegawa, T; Kurokawa, K; Onishi, Y; Yamaguchi, T1
Alvarez-Ude, F; Arenas, MD; Carretón, MA; Devesa, R; Gil, MT; Malek, T; Moledous, A; Nuñez, C; Soriano, A1
Brancaccio, D; Cozzolino, M; Galassi, A1
Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H1

Reviews

15 review(s) available for cinacalcet and Bone Diseases, Metabolic

ArticleYear
What have we learned about chronic kidney disease-mineral bone disorder from the EVOLVE and PRIMO trials?
    Current opinion in nephrology and hypertension, 2013, Volume: 22, Issue:6

    Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic

2013
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Clinical calcium, 2016, Volume: 26, Issue:2

    Topics: Bone and Bones; Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Cinacalcet; Ferric Compounds; Fractures, Bone; Humans; Minerals; Parathyroidectomy; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Risk Factors; Sevelamer

2016
Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:10

    Topics: Bone Diseases, Metabolic; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Minerals; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D

2016
[Chronic kidney disease (CKD) and bone. Control of CKD-MBD from the viewpoint of the medical cost].
    Clinical calcium, 2009, Volume: 19, Issue:4

    Topics: Bone Diseases, Metabolic; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit Analysis; Costs and Cost Analysis; Economics, Pharmaceutical; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroidectomy; Policy Making; Polyamines; Sevelamer; Vitamin D

2009
Management of mineral and bone disorder in chronic kidney disease: quo vadis?
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2009, Volume: 13 Suppl 1

    Topics: Bone Diseases, Metabolic; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Vitamin D; Vitamins

2009
Treatment with calcimimetics in kidney transplantation.
    Transplantation reviews (Orlando, Fla.), 2010, Volume: 24, Issue:2

    Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency

2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].
    Clinical calcium, 2010, Volume: 20, Issue:7

    Topics: Bone Density; Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Dialysis; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Naphthalenes; Practice Guidelines as Topic

2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
    Clinical calcium, 2010, Volume: 20, Issue:7

    Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Polyamines; Prognosis; Risk; Sevelamer; Survival Rate; Vascular Diseases; Vitamin D

2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
    Clinical calcium, 2010, Volume: 20, Issue:7

    Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Vascular Diseases; Vitamin D

2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].
    Clinical calcium, 2010, Volume: 20, Issue:7

    Topics: Bone Diseases, Metabolic; Calcitriol; Chelating Agents; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroidectomy; Polyamines; Practice Guidelines as Topic; Receptors, Calcium-Sensing; Sevelamer; Uremia; Vitamin D

2010
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
    Clinical calcium, 2011, Volume: 21, Issue:12

    Topics: Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Lanthanum; Membrane Proteins; Naphthalenes; Vascular Calcification; Vitamin D

2011
The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis.
    Endocrine, 2013, Volume: 43, Issue:1

    Topics: Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcification, Physiologic; Calcimimetic Agents; Calcium, Dietary; Chelating Agents; Cinacalcet; Combined Modality Therapy; Dietary Supplements; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Peritoneal Dialysis; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Vitamin D

2013
[Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
    Clinical calcium, 2012, Volume: 22, Issue:7

    Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diphosphonates; Fractures, Spontaneous; Homeostasis; Humans; Kidney Diseases; Minerals; Naphthalenes; Osteoporosis; Phosphorus; Renal Dialysis; Risk

2012
[Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
    Clinical calcium, 2012, Volume: 22, Issue:7

    Topics: Bone Diseases, Metabolic; Carbamates; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit Analysis; Humans; Kidney Diseases; Lanthanum; Minerals; Naphthalenes; Parathyroidectomy; Polyamines; Sevelamer; Vitamin D

2012
CKD-MBD: impact on management of kidney disease.
    Clinical and experimental nephrology, 2007, Volume: 11, Issue:4

    Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins

2007

Trials

3 trial(s) available for cinacalcet and Bone Diseases, Metabolic

ArticleYear
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:12

    Topics: Adult; Aged; Bone Diseases, Metabolic; Calcimimetic Agents; Cinacalcet; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Proportional Hazards Models; Renal Dialysis; Severity of Illness Index

2013
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:4

    Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Ergocalciferols; Female; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome

2014
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
    Kidney international, 2015, Volume: 87, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Diseases, Metabolic; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteogenesis; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Young Adult

2015

Other Studies

14 other study(ies) available for cinacalcet and Bone Diseases, Metabolic

ArticleYear
Cinacalcet use in pediatric chronic kidney disease. A survey study.
    Saudi medical journal, 2020, Volume: 41, Issue:5

    Topics: Age Factors; Bone Diseases, Metabolic; Child; Child, Preschool; Cinacalcet; Female; Humans; Hyperparathyroidism; Infant; Male; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Surveys and Questionnaires; Treatment Outcome

2020
Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2013, Volume: 17, Issue:3

    Topics: Adult; Aged; Algorithms; Bone Diseases, Metabolic; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Sterols; Time Factors; Vitamin D

2013
Regression of tumoral calcinosis after the appropriate control of a deranged mineral and bone metabolism, in conjugation with cinacalcet hydrochloride treatment, in a chronic hemodialysis patient.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2013, Volume: 17, Issue:3

    Topics: Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Naphthalenes; Renal Dialysis; Treatment Outcome; Uremia

2013
Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis.
    Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:2

    Topics: Aged; Aged, 80 and over; Bone Diseases, Metabolic; Cinacalcet; Dialysis; Drug Administration Schedule; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Quality of Life

2015
Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2014, Volume: 25, Issue:6

    Topics: Adult; Aged; Biomarkers; Bone Diseases, Metabolic; Chelating Agents; Cinacalcet; Cost-Benefit Analysis; Dietary Supplements; Drug Costs; Female; Humans; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Saudi Arabia; Time Factors; Treatment Outcome; Up-Regulation; Vascular Calcification; Vitamin D

2014
Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2015, Volume: 35, Issue:4

    Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Cinacalcet; Drug Substitution; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Postoperative Complications; Retrospective Studies

2015
Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2008, Volume: 18, Issue:4

    Topics: Bone and Bones; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Quality of Health Care; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D

2008
Use of cinacalcet HCl to achieve the recommended targets of bone metabolism in a patient with therapy-resistant renal hyperparathyroidism.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2008, Volume: 18, Issue:4

    Topics: Adult; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Weight Gain

2008
Emerging roles of cinacalcet hydrochloride in the management of CKD-MBD.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2009, Volume: 13 Suppl 1

    Topics: Bone Diseases, Metabolic; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Terminology as Topic

2009
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:1

    Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency

2010
Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:4

    Topics: Bone Diseases, Metabolic; Calcinosis; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Prognosis; Renal Dialysis; Vitamin D; Vitamins

2011
Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
    Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:9

    Topics: Aged; Biomarkers; Bone Diseases, Metabolic; Calcimimetic Agents; Calcium; Cinacalcet; Drug Prescriptions; Drug Utilization; Drug Utilization Review; Female; Humans; Hyperparathyroidism, Secondary; Japan; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Patterns, Physicians'; Prevalence; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vitamin D

2012
Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:6

    Topics: Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Female; Humans; Hyperparathyroidism; Kidney Diseases; Male; Middle Aged; Naphthalenes; Practice Guidelines as Topic; Renal Dialysis; Vitamin D

2007
Cinacalcet, paricalcitol, or both?
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:10

    Topics: Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Hyperparathyroidism; Kidney Diseases; Naphthalenes; Practice Guidelines as Topic; Renal Dialysis; Vitamin D

2007